Literature DB >> 17000938

Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.

Stephen B Soumerai1, Marsha Pierre-Jacques, Fang Zhang, Dennis Ross-Degnan, Alyce S Adams, Jerry Gurwitz, Gerald Adler, Dana Gelb Safran.   

Abstract

BACKGROUND: Prior to implementation of the Medicare drug benefit, we estimated the prevalence of cost-related medication nonadherence (CRN) among Medicare enrollees, including elderly and nonelderly disabled beneficiaries.
METHODS: In the fall of 2004, detailed measures of CRN (skipping or reducing doses or not filling prescriptions because of cost) were added to the Medicare Current Beneficiary Survey. We examined the prevalence of CRN nationally and by Medicare eligibility subgroups (elderly vs nonelderly disabled beneficiaries), drug coverage status, socioeconomic status, self-rated health, and number of chronic medical conditions.
RESULTS: In a national sample of 13 835 noninstitutionalized Medicare enrollees, 29% of the disabled and 13% of the elderly beneficiaries reported CRN; those in fair to poor health with multiple comorbidities and without coverage were most at risk. Among the disabled enrollees with 4 or more morbidities, 52% (95% confidence interval [CI], 43.3%-60.3%) without drug coverage skipped prescriptions or doses compared with 26% (95% CI, 17.7%-34.8%) with Medicaid drug coverage. Those with partial drug coverage through Medigap policies or Medicare health maintenance organizations reported intermediate rates of CRN. The adjusted odds ratio of CRN among disabled enrollees in poor (vs good) health was 3.9 (95% CI, 1.7-9.2), whereas for those with 4 or more (vs <4) comorbidities, the odds ratio of CRN was 2.7 (95% CI, 1.7-4.1).
CONCLUSIONS: One year before Medicare Part D implementation, Medicare beneficiaries reported high rates of CRN. Rates are highest among nonelderly disabled beneficiaries, but among both elderly and disabled beneficiaries, CRN is exacerbated by poor health, multiple morbidities, and limited drug coverage. Given the high cost sharing under Part D, it is important to closely monitor CRN in high-risk subgroups.

Mesh:

Year:  2006        PMID: 17000938     DOI: 10.1001/archinte.166.17.1829

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  94 in total

1.  The doughnut hole: it's about medication adherence.

Authors:  Christianne L Roumie
Journal:  Ann Intern Med       Date:  2012-06-05       Impact factor: 25.391

2.  Association between sitagliptin adherence and self-monitoring of blood glucose.

Authors:  Somesh Nigam; Naunihal S Virdi; Mehmet Daskiran; Chris M Kozma; Andrew Paris; William M Dickson
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

3.  US pharmaceutical innovation in an international context.

Authors:  Salomeh Keyhani; Steven Wang; Paul Hebert; Daniel Carpenter; Gerard Anderson
Journal:  Am J Public Health       Date:  2010-04-19       Impact factor: 9.308

4.  Food Insecurity and Cost-Related Medication Underuse Among Nonelderly Adults in a Nationally Representative Sample.

Authors:  Dena Herman; Patience Afulani; Alisha Coleman-Jensen; Gail G Harrison
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

5.  Gender differences in cost-related medication non-adherence among cancer survivors.

Authors:  Minjee Lee; M Mahmud Khan
Journal:  J Cancer Surviv       Date:  2015-09-09       Impact factor: 4.442

6.  Rationale and study protocol for a multi-component Health Information Technology (HIT) screening tool for depression and post-traumatic stress disorder in the primary care setting.

Authors:  Kelly Biegler; Richard Mollica; Susan Elliott Sim; Elisa Nicholas; Maria Chandler; Quyen Ngo-Metzger; Kittya Paigne; Sompia Paigne; Danh V Nguyen; Dara H Sorkin
Journal:  Contemp Clin Trials       Date:  2016-07-06       Impact factor: 2.226

7.  The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes.

Authors:  Quyen Ngo-Metzger; Dara H Sorkin; John Billimek; Sheldon Greenfield; Sherrie H Kaplan
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

8.  Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.

Authors:  Jessica Williams; William N Steers; Susan L Ettner; Carol M Mangione; Obidiugwu K Duru
Journal:  Med Care       Date:  2013-02       Impact factor: 2.983

9.  Cost-related medication nonadherence in older patients with rheumatoid arthritis.

Authors:  Leslie R Harrold; Becky A Briesacher; Dan Peterson; Ashley Beard; Jeanne Madden; Fang Zhang; Jerry H Gurwitz; Stephen B Soumerai
Journal:  J Rheumatol       Date:  2013-01-15       Impact factor: 4.666

10.  Medicare Part D coverage gap and diabetes beneficiaries.

Authors:  Julie A Schmittdiel; Susan L Ettner; Vicki Fung; Jie Huang; Norman Turk; Elaine S Quiter; Bix E Swain; John T Hsu; Carol M Mangione
Journal:  Am J Manag Care       Date:  2009-03       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.